MEC Plus

Radiation in Early-Stage NSCLC
Radiation in Early-Stage NSCLC
Megan Daly, MD
Surgery for Early-Stage NSCLC
Surgery for Early-Stage NSCLC
Johannes Kratz, MD, PhD
Adjuvant/Neo-adjuvant Systemic Therapy
Adjuvant/Neo-adjuvant Systemic Therapy
Heather Wakelee, MD
Pulmonary – From Diagnostics to Therapeutics
Pulmonary – From Diagnostics to Therapeutics
Nicholas Stollenwerk, MD
Lung Cancer Screening / Tobacco Control
Lung Cancer Screening / Tobacco Control
David T. Cooke, MD
Hematology Session III
Hematology Session III
Francine Foss, Eduardo Sotomayor, Nakhle Saba
Hematology Session II
Hematology Session II
Sikander Ailawadhi, Javier Pinilla-Ibarz, Lisa Welsh
Hematology Session I
Hematology Session I
Rami Komrokji, Mohamed Kharfan-Dabaja, Guillermo Garcia-Manero
Thoracic Oncology Session
Thoracic Oncology Session
Rita Axelrod, Joshua Bauml, Luis Raez, Janakiraman Subramanian, Primo Lara Jr.
Immunotherapy in Oncology Session II
Immunotherapy in Oncology Session II
Laura Zitella, Gerardo Colon-Otero, Daniel Petrylak, David Gandara
Immunotherapy in Oncology Session I
Immunotherapy in Oncology Session I
Hossein Borghaei, David Quinn, Sanjiv Agarwala
Anticoagulation in Oncology: What’s New?
Anticoagulation in Oncology: What’s New?
Craig S. Kitchens, MD, MACP
Liquid Biopsy: Indications in Oncology and Hematology
Liquid Biopsy: Indications in Oncology and Hematology
Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Palliative Care and the Importance of Advanced Care Planning
Palliative Care and the Importance of Advanced Care Planning
Sarah Lowry, DNP, ACNP-BC, AOCNP, ACHPH
Integration of Biosimilars in Oncology Care
Integration of Biosimilars in Oncology Care
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Novel Targeted Therapeutic Approaches for Breast Cancer
Novel Targeted Therapeutic Approaches for Breast Cancer
Mark Pegram, MD
HER2+ Breast Cancer: De-escalating Therapy for Early Stage Disease and Optimal Sequencing for Metastatic Disease
HER2+ Breast Cancer: De-escalating Therapy for Early Stage Disease and Optimal Sequencing for Metastatic Disease
Helen K. Chew, MD
New Directions in Adjuvant Endocrine Therapy
New Directions in Adjuvant Endocrine Therapy
Marianna Chavez-MacGregor, MD
Immunotherapy in Breast Cancer: Recent Updates
Immunotherapy in Breast Cancer: Recent Updates
Edith A. Pérez, MD
Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K
Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K
Hope S. Rugo, MD
Impact of COVID-19 on Cancer Care
Impact of COVID-19 on Cancer Care
Jessica MacIntyre, MSN, APRN, NP-C, AOCNP®
Integrating Biomarkers and Targeted Therapy into Colorectal Management
Integrating Biomarkers and Targeted Therapy into Colorectal Management
Mitesh J. Borad, MD
Gastric and Esophageal Cancers
Gastric and Esophageal Cancers
Thomas Reske, MD, PhD, FACP, CMD
Colon Cancer: Where Are We?
Colon Cancer: Where Are We?
Axel Grothey, MD
Emerging Combination in Sarcoma Immunotherapy
Emerging Combination in Sarcoma Immunotherapy
Pasquale W. Benedetto, MD
Bring New & Innovative Glioblastoma Treatments to the Clinical Practice
Bring New & Innovative Glioblastoma Treatments to the Clinical Practice
Sajeel Chowdhary, MD
Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn
Natural Disasters: Infamy vs. Nature – What Lessons Can We Learn
Antonia Coello Novello, MD, MPH, DR.PH
T-cell NHL: Novel Treatments
T-cell NHL: Novel Treatments
Steven Horwitz, MD
Melanoma: What Is the Best Sequence of Therapy?
Melanoma: What Is the Best Sequence of Therapy?
Sanjiv Agarwala, MD